PharmaTimes https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Wed, 29 Apr 2026 13:38:39 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png PharmaTimes https://pharmatimes.com 32 32 232894315 Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy https://pharmatimes.com/news/kahimmune-therapeutics-signs-collaboration-agreement-with-gustave-roussy/ Wed, 29 Apr 2026 13:37:49 +0000 https://pharmatimes.com/?p=104486 Partnership to support selection of first neoantigen therapy candidate

]]> 104486 BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development https://pharmatimes.com/news/bioduro-and-cti-biotechnology-form-partnership-to-accelerate-preclinical-drug-development/ Wed, 29 Apr 2026 12:43:38 +0000 https://pharmatimes.com/?p=104484 Collaboration aims to create integrated platform from discovery to IND submission

]]> 104484 Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026 https://pharmatimes.com/news/asgard-therapeutics-to-present-new-preclinical-data-on-at-108-at-asgct-2026/ Tue, 28 Apr 2026 08:51:33 +0000 https://pharmatimes.com/?p=104482 Lead asset shows systemic, dose‑dependent anti‑tumour activity

]]> 104482 Theolytics announces first patient dosed in the Octopod‑IP trial https://pharmatimes.com/news/theolytics-announces-first-patient-dosed-in-the-octopod-ip-trial/ Tue, 28 Apr 2026 08:36:48 +0000 https://pharmatimes.com/?p=104480 US study marks company’s second clinical trial of ovarian cancer therapy

]]> 104480 UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention https://pharmatimes.com/news/uk-medicines-regulator-grants-marketing-authorisation-to-enflonsia-for-rsv-prevention/ Mon, 27 Apr 2026 09:39:40 +0000 https://pharmatimes.com/?p=104478 Clesrovimab is first monoclonal antibody offering a single fixed dose for infants

]]> 104478 Saphnelo approved in the US for subcutaneous self‑administration https://pharmatimes.com/news/saphnelo-approved-in-the-us-for-subcutaneous-self-administration/ Mon, 27 Apr 2026 09:17:37 +0000 https://pharmatimes.com/?p=104476 Greater flexibility for people with systemic lupus erythematosus

]]> 104476 Transgene completes randomisation in phase 2 trial of tg4050 https://pharmatimes.com/news/transgene-completes-randomisation-in-phase-2-trial-of-tg4050/ Mon, 13 Apr 2026 08:34:12 +0000 https://pharmatimes.com/?p=104474 Company expects two‑year dfs data by q1 2028

]]> 104474 Bayer wins MHRA approval for Kerendia in heart failure https://pharmatimes.com/news/bayer-wins-mhra-approval-for-kerendia-in-heart-failure/ Mon, 13 Apr 2026 08:24:42 +0000 https://pharmatimes.com/?p=104472 New authorisation offers additional option for patients with lvef ≥40%

]]> 104472 Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb https://pharmatimes.com/news/oxford-biotherapeutics-signs-collaboration-with-bristol-myers-squibb/ Thu, 09 Apr 2026 12:59:54 +0000 https://pharmatimes.com/?p=104463 Partnership to develop next‑generation T‑cell engagers for solid tumours

]]> 104463 Kainova expands DT 7012 trial into Europe https://pharmatimes.com/news/kainova-expands-dt-7012-trial-into-europe/ Thu, 09 Apr 2026 12:48:48 +0000 https://pharmatimes.com/?p=104460 First patient dosed as DOMISOL study grows beyond Australia

]]> 104460